SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): August 9, 2007 (August 9,
2007)
CHEMBIO
DIAGNOSTICS, INC.
(Exact
name of registrant as specified in its charter)
|
Nevada
|
0-30379
|
88-0425691
|
||
|
(State
or other jurisdiction
|
(Commission
File Number)
|
(IRS
Employer
|
||
|
of
Incorporation)
|
Identification
Number)
|
|||
|
3661
Horseblock Road
|
||||
|
Medford,
NY 11763
|
||||
|
(Address
of principal executive offices)
|
||||
|
631-924-1135
|
||||
|
(Registrant’s
Telephone Number)
|
N/A
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
ITEM
2.02. Results of Operations and Financial
Condition
To
the
extent applicable, the information disclosed under Item 7.01 and Exhibit
99.1 is incorporated herein by reference.
ITEM
7.01. Regulation FD Disclosures
On
August
9, 2007, the Company issued the press release titled “Chembio Reports Second
Quarter Financial Results” included herein as Exhibit 99.1.
On
July
31, 2007, the Company issued the press release titled “Chembio and Pall
Corporation Enter DPP™ Collaboration” included herein as Exhibit
99.2.
ITEM
9.01. Financial Statements and Exhibits
Exhibits.
|
99.1
|
Press
Release titled “Chembio
Reports Second Quarter Financial
Results” issued
August 9, 2007.
|
|
99.2
|
Press
Release titled “Chembio
and Pall Corporation Enter DPP™
Collaboration”
issued July 31, 2007.
|
In
accordance with General Instruction B.2 of Form 8-K, the information disclosed
in Items 2.02 and 7.01 of, and Exhibits 99.1 and 99.2 attached to, this Current
Report on Form 8-K shall not be deemed “filed” for the purpose of Section 18 of
the Securities Exchange Act of 1934, nor shall it be deemed incorporated by
reference in any filing. This Current Report on Form 8-K does not
constitute a determination of whether any information included herein is
material.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
Date: August 9,
2007 Chembio
Diagnostics, Inc.
By: /s/
Lawrence A.
Siebert
Lawrence A. Siebert
Chief Executive Officer